Olympus Co. (OTCMKTS:OLYMY) Sees Significant Drop in Short Interest

Olympus Co. (OTCMKTS:OLYMY) was the recipient of a large decline in short interest in the month of July. As of July 31st, there was short interest totaling 17,276 shares, a decline of 60.1% from the July 15th total of 43,336 shares. Based on an average trading volume of 100,297 shares, the short-interest ratio is presently 0.2 days.

Olympus Price Performance

Shares of OTCMKTS OLYMY opened at $13.15 on Friday. The company’s fifty day moving average is $11.06 and its 200-day moving average is $10.55. Olympus has a twelve month low of $8.08 and a twelve month high of $13.73.

Analyst Ratings Changes

Separately, The Goldman Sachs Group cut shares of Olympus from a “buy” rating to a “neutral” rating in a research report on Monday, June 15th. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the company currently has an average rating of “Hold”.

Olympus Company Profile

Olympus Corporation is a Tokyo-based manufacturer specializing in precision technology for the medical, scientific and industrial markets. Established in 1919, the company has built an international reputation for optical and digital imaging solutions that encompass endoscopic systems, microscopes, cameras and related accessories. Olympus leverages its expertise in optics, mechanics and electronics to develop instruments designed to advance diagnostics and scientific discovery.

In the healthcare sector, Olympus is best known for its endoscopy products and therapeutic solutions that support minimally invasive procedures in gastroenterology, pulmonology and urology.